BAX
Price
$26.37
Change
+$0.58 (+2.25%)
Updated
Nov 9, 03:36 PM (EDT)
Capitalization
13.33B
101 days until earnings call
Intraday BUY SELL Signals
SYK
Price
$326.27
Change
+$0.40 (+0.12%)
Updated
Nov 9, 03:29 PM (EDT)
Capitalization
124.99B
85 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BAX vs SYK

BAX vs SYK Comparison Chart in %
View a ticker or compare two or three
VS
BAX vs. SYK commentary
Nov 09, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAX is a Hold and SYK is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for BAX with price predictions
Nov 06, 2026

BAX's RSI Oscillator recovers from overbought zone

The 10-day RSI Indicator for BAX moved out of overbought territory on October 16, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 instances where the indicator moved out of the overbought zone. In 25 of the 32 cases the stock moved lower in the days that followed. This puts the odds of a move down at 78%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BAX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 03, 2026. You may want to consider a long position or call options on BAX as a result. In 45 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 53%.

The Moving Average Convergence Divergence (MACD) for BAX just turned positive on November 04, 2026. Looking at past instances where BAX's MACD turned positive, the stock continued to rise in 19 of 46 cases over the following month. The odds of a continued upward trend are 41%.

BAX moved above its 50-day moving average on November 03, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for BAX crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 69%.

Following a +9.41% 3-day Advance, the price is estimated to grow further. Considering data from situations where BAX advanced for three days, in 166 of 285 cases, the price rose further within the following month. The odds of a continued upward trend are 58%.

BAX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 146 of 210 cases where BAX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 70%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. BAX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 68 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 92 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.148) is normal, around the industry mean (4.964). P/E Ratio (-12.459) is within average values for comparable stocks, (40.591). BAX's Projected Growth (PEG Ratio) (36.677) is very high in comparison to the industry average of (4.143). Dividend Yield (0.002) settles around the average of (0.005) among similar stocks. P/S Ratio (1.057) is also within normal values, averaging (56.876).

The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BAX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for SYK with price predictions
Nov 06, 2026

SYK in +10.70% Uptrend, growing for three consecutive days on November 04, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where SYK advanced for three days, in 174 of 305 cases, the price rose further within the following month. The odds of a continued upward trend are 57%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 02, 2026. You may want to consider a long position or call options on SYK as a result. In 51 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 57%.

SYK moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for SYK crossed bullishly above the 50-day moving average on October 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 45%.

The Aroon Indicator entered an Uptrend today. In 128 of 258 cases where SYK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 50%.

Bearish Trend Analysis

The 10-day RSI Indicator for SYK moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In 20 of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at 53%.

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SYK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 50%.

SYK broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. SYK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 52 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 59 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron Valuation Rating of 79 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.211) is normal, around the industry mean (4.142). P/E Ratio (33.491) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (1.289) is also within normal values, averaging (11.253). Dividend Yield (0.011) settles around the average of (0.011) among similar stocks. P/S Ratio (4.259) is also within normal values, averaging (40.124).

The Tickeron PE Growth Rating for this company is 79 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

FUNDAMENTALS RATINGS
BAX vs SYK: Fundamental Ratings
BAX
SYK
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
79
Overvalued
PROFIT vs RISK RATING
1..100
10059
SMR RATING
1..100
9452
PRICE GROWTH RATING
1..100
3943
P/E GROWTH RATING
1..100
6879
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SYK's Valuation (79) in the Medical Specialties industry is in the same range as BAX (92). This means that SYK’s stock grew similarly to BAX’s over the last 12 months.

SYK's Profit vs Risk Rating (59) in the Medical Specialties industry is somewhat better than the same rating for BAX (100). This means that SYK’s stock grew somewhat faster than BAX’s over the last 12 months.

SYK's SMR Rating (52) in the Medical Specialties industry is somewhat better than the same rating for BAX (94). This means that SYK’s stock grew somewhat faster than BAX’s over the last 12 months.

BAX's Price Growth Rating (39) in the Medical Specialties industry is in the same range as SYK (43). This means that BAX’s stock grew similarly to SYK’s over the last 12 months.

BAX's P/E Growth Rating (68) in the Medical Specialties industry is in the same range as SYK (79). This means that BAX’s stock grew similarly to SYK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BAXSYK
RSI
ODDS (%)
Bearish Trend 4 days ago
78%
Bearish Trend 4 days ago
53%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
65%
Bearish Trend 4 days ago
55%
Momentum
ODDS (%)
Bullish Trend 4 days ago
53%
Bullish Trend 4 days ago
57%
MACD
ODDS (%)
Bullish Trend 4 days ago
41%
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
60%
Bullish Trend 4 days ago
57%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
64%
Bullish Trend 4 days ago
50%
Advances
ODDS (%)
Bullish Trend 6 days ago
58%
Bullish Trend 6 days ago
57%
Declines
ODDS (%)
Bearish Trend 11 days ago
67%
Bearish Trend 4 days ago
50%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
60%
Bearish Trend 4 days ago
63%
Aroon
ODDS (%)
Bullish Trend 4 days ago
70%
Bullish Trend 4 days ago
50%
COMPARISON
Comparison
Nov 09, 2026
Stock price -- (BAX: $25.79 vs. SYK: $325.87)
Brand notoriety: BAX and SYK are both not notable
BAX represents the Pharmaceuticals: Other, while SYK is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: BAX: 88% vs. SYK: 125%
Market capitalization -- BAX: $13.33B vs. SYK: $124.99B
BAX [@Pharmaceuticals: Other] is valued at $13.33B. SYK’s [@Medical/Nursing Services] market capitalization is $124.99B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $159.96B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $190.22B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $9.78B. The average market capitalization across the [@Medical/Nursing Services] industry is $6.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BAX’s FA Score shows that 0 FA rating(s) are green while SYK’s FA Score has 0 green FA rating(s).

  • BAX’s FA Score: 0 green, 5 red.
  • SYK’s FA Score: 0 green, 5 red.
According to our system of comparison, SYK is a better buy in the long-term than BAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BAX’s TA Score shows that 7 TA indicator(s) are bullish while SYK’s TA Score has 5 bullish TA indicator(s).

  • BAX’s TA Score: 7 bullish, 3 bearish.
  • SYK’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, BAX is a better buy in the short-term than SYK.

Price Growth

BAX (@Pharmaceuticals: Other) experienced а +12.13% price change this week, while SYK (@Medical/Nursing Services) price change was +11.65% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +5.45%. For the same industry, the average monthly price growth was +4.64%, and the average quarterly price growth was +18.65%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +35.79%. For the same industry, the average monthly price growth was +17.54%, and the average quarterly price growth was +8.10%.

Reported Earning Dates

BAX is expected to report earnings on Feb 18, 2027.

SYK is expected to report earnings on Feb 02, 2027.

Industries' Descriptions

@Pharmaceuticals: Other (+5.45% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (+35.79% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

SYK and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYK has been loosely correlated with ISRG. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if SYK jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYK
1D Price
Change %
SYK100%
-2.75%
ISRG - SYK
65%
Loosely correlated
-3.36%
MDT - SYK
62%
Loosely correlated
-2.90%
ZBH - SYK
59%
Loosely correlated
-1.18%
STE - SYK
58%
Loosely correlated
-0.72%
A - SYK
56%
Loosely correlated
+1.73%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
VIC.X0.003179-0.000044
-1.37%
Viction cryptocurrency
LRC.X0.007164-0.000236
-3.19%
Loopring cryptocurrency
ZEC.X1207.651500-52.558960
-4.17%
Zcash cryptocurrency
AXS.X0.786223-0.043382
-5.23%
Axie Infinity cryptocurrency
PEOPLE.X0.005684-0.000347
-5.75%
ConstitutionDAO cryptocurrency